The American Joint Committee on Cancer's Cancer Staging Manual is used by physicians throughout the world to diagnose cancer and determine the extent to which cancer has progressed. All of the TNM staging information included in this Sixth Edition is uniform between the AJCC (American Joint Committee on Cancer) and the UICC (International Union Against Cancer). In addition to the information found in the Handbook, the Manual provides standardized data forms for each anatomic site, which can be utilized as permanent patient records, enabling clinicians and cancer research scientists to maintain consistency in evaluating the efficacy of diagnosis and treatment. The CD-ROM packaged with each Manual contains printable copies of each of the book’s 45 Staging Forms.

In many ways, the field of lung cancer research is leading the way in personalized oncologic care, with numerous new treatment strategies moving from clinical trials to standard clinical practice within the past 10 years; and, there are no indications of bench-to-bedside innovations slowing down. Handbook of Thoracic Oncology is a practical guide to the multidisciplinary management of patients with lung cancer and other thoracic malignancies. The content highlights the applications of both conventional and novel treatment strategies to the care of real-life patients with lung cancer. Unlike many oncology textbooks that exhaustively list studies of historical or failed approaches, this handbook focuses on the application of practical, current management options to specific patient subsets and the data that specifically support these strategies. The format is open and readable with bulleted points presenting overall treatment guidelines as well as more nuanced applications of these treatments to individual patient groups. The clear focus of this book is on the question that all oncologists ask themselves every day, “How do I take care of this person sitting in front of me?” This handbook is an indispensable guide for all oncologists and practitioners who regularly care for lung cancer patients and those suffering from mesothelioma, thymic tumors, and pulmonary neuro-endocrine tumors. Features: Delivers the need-to-know points of lung cancer screening, diagnosis and staging, and appropriate multidisciplinary management for all major thoracic malignancies Provides clinical pearls and treatment recommendations for patients who don’t ‘fit’ the standard guidelines Includes specific coverage on Management of Elderly and High-Risk Patients Prepares physicians to notice and eliminate common errors in clinical practice when managing patients with lung cancer and other thoracic tumors

What is my prognosis? What are my treatment options? Which therapies would be the most effective for my stage of lung cancer? These and other frequently asked questions are addressed in this crucial reference designed to help patients educate themselves and obtain the best possible treatments. The completely revised second edition has been updated to include a discussion of the movement towards customized chemotherapy; treatment options for early-stage lung cancer including minimally invasive surgery; and the most promising treatments, among them multimodality therapy—a combination of surgery, chemotherapy, and radiation. Dr. Scott also surveys tests for early detection of lung cancer, talks about the importance of cancer staging, examines alternative treatments, and offers advice on coping with emotions such as "smoker's guilt."

An accessible handbook covering thoracic surgery topics, with comprehensive guidance for trainees, cardiothoracic surgeons and consultants.

This book describes the molecular mechanisms of lung cancer development and progression that determine therapeutic interventions in the era of genomics, when the rapid evolution in lung cancer diagnosis and treatment necessitates critical review of new results to integrate advances into practice. The text opens with background and emerging information regarding the molecular biology of lung cancer pathogenesis. Updated results regarding lung cancer prevention and screening are discussed, followed by chapters on diagnostic techniques and pathological evaluation. This leads on to a detailed presentation of treatment modalities, from surgery and radiation therapy to standard chemotherapy and targeted agents. The coverage includes resistance to therapy and the emergence of immunotherapy for lung cancer; in addition, the current evidence in respect of small cell lung cancer is summarized. The book presents insights from experts across disciplines to emphasize the importance of collaborative care. Advances in our understanding of issues in geriatric oncology and palliative care complete the comprehensive discussion of lung cancer.